Syncom Formulations India declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 13.52% & the profit increased by 68.92% YoY. As compared to the previous quarter, the revenue grew by 2.04% and the profit increased by 7.52%.
The selling, general & administrative expenses rose by 8.17% QoQ and increased by 34.17% YoY.
The operating income was up by 6.51% QoQ and increased by 25.16% YoY.
The EPS is ₹0.09 for Q3 FY24, which increased by 50.38% YoY.
Syncom Formulations India has delivered -1.89% return in the last 1 week, 85.12% return in the last 6 months, and 3.32% YTD return.
Currently, Syncom Formulations India has a market cap of ₹1461.7 Cr and a 52-week high/low of ₹18.65 & ₹4.6 respectively.
Syncom Formulations India Financials
Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 65.14 | 63.84 | +2.04% | 57.38 | +13.52% |
Selling/ General/ Admin Expenses Total | 9.74 | 9 | +8.17% | 7.26 | +34.17% |
Depreciation/ Amortization | 1.45 | 0.88 | +64.52% | 1.2 | +20.33% |
Total Operating Expense | 59.25 | 58.31 | +1.61% | 52.68 | +12.48% |
Operating Income | 5.89 | 5.53 | +6.51% | 4.7 | +25.16% |
Net Income Before Taxes | 9.36 | 8.45 | +10.8% | 5.97 | +56.92% |
Net Income | 7 | 6.51 | +7.52% | 4.14 | +68.92% |
Diluted Normalized EPS | 0.09 | 0.08 | +12.79% | 0.06 | +50.38% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.